Can we identify novel angiogenesis inhibitors from cultured embryonic cells?
- 1 March 2003
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 60 (3) , 389-390
- https://doi.org/10.1016/s0306-9877(02)00408-5
Abstract
No abstract availableKeywords
Funding Information
- Suzuken Memorial Foundation
- Ministry of Education, Culture, Sports, Science and Technology
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
This publication has 10 references indexed in Scilit:
- Insulin Stimulates the Growth and Tube Formation of Human Microvascular Endothelial Cells through Autocrine Vascular Endothelial Growth FactorMicrovascular Research, 1999
- Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195Diabetologia, 1999
- Upregulation of Retinal Vascular Endothelial Growth Factor mRNAs in Spontaneously Diabetic Rats without Ophthalmoscopic RetinopathyOphthalmic Research, 1998
- Angiogenesis in Embryos and Ischemic DiseasesThrombosis and Haemostasis, 1997
- Advanced Glycation End Products-driven Angiogenesis in VitroJournal of Biological Chemistry, 1997
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityNature Medicine, 1995
- Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related PeptidesScience, 1990
- Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis.The Journal of cell biology, 1988
- Mechanisms of AngiogenesisAnnual Review of Physiology, 1987
- Angiogenesis in vitroNature, 1980